Skip to main content
Clinical Trials/JPRN-UMIN000044076
JPRN-UMIN000044076
Recruiting
Phase 4

The efficacy of progestin primed ovarian stimulation (PPOS) using Dienogest v.s. antagonist method for patients with endometriosis - PPOS using Diengoest for patients with endometriosis

Kamiya Ladies Clinic0 sites80 target enrollmentMay 1, 2021
Conditionsinfertility

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
infertility
Sponsor
Kamiya Ladies Clinic
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2021
End Date
April 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who documented cycles with no oocyte retrieved, an y contraindications to ovarian stimulation treatment and 2\) patients who has contraindication to DNG, GnRHa, EP, FSH, HMG, HCG 3\) Using other hormonal therapy except Dienogest over 2 months before COS 4\) Patients who is judged to be inappropriate for this study by th e doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials